IRIS Accounts Production v24.1.4.33 12727107 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh127271072023-03-31127271072024-03-31127271072023-04-012024-03-31127271072022-03-31127271072022-04-012023-03-31127271072023-03-3112727107ns15:EnglandWales2023-04-012024-03-3112727107ns14:PoundSterling2023-04-012024-03-3112727107ns10:Director12023-04-012024-03-3112727107ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112727107ns10:SmallEntities2023-04-012024-03-3112727107ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112727107ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3112727107ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112727107ns10:FullAccounts2023-04-012024-03-311272710712023-04-012024-03-3112727107ns10:OrdinaryShareClass12023-04-012024-03-3112727107ns10:Director22023-04-012024-03-3112727107ns10:RegisteredOffice2023-04-012024-03-3112727107ns5:CurrentFinancialInstruments2024-03-3112727107ns5:CurrentFinancialInstruments2023-03-3112727107ns5:ShareCapital2024-03-3112727107ns5:ShareCapital2023-03-3112727107ns5:RetainedEarningsAccumulatedLosses2024-03-3112727107ns5:RetainedEarningsAccumulatedLosses2023-03-3112727107ns5:NetGoodwill2023-04-012024-03-3112727107ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112727107ns5:FurnitureFittings2023-04-012024-03-3112727107ns5:MotorVehicles2023-04-012024-03-3112727107ns5:NetGoodwill2023-03-3112727107ns5:NetGoodwill2024-03-3112727107ns5:NetGoodwill2023-03-3112727107ns5:FurnitureFittings2023-03-3112727107ns5:MotorVehicles2023-03-3112727107ns5:FurnitureFittings2024-03-3112727107ns5:MotorVehicles2024-03-3112727107ns5:FurnitureFittings2023-03-3112727107ns5:MotorVehicles2023-03-3112727107ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3112727107ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3112727107ns5:DeferredTaxation2023-03-3112727107ns5:DeferredTaxation2023-04-012024-03-3112727107ns5:DeferredTaxation2024-03-3112727107ns10:OrdinaryShareClass12024-03-3112727107ns5:RetainedEarningsAccumulatedLosses2023-03-3112727107ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 12727107 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2024

for

CHURCH PHARMA (BILSTON) LTD

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHURCH PHARMA (BILSTON) LTD

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Mohan Lal Sahni
Jaswinder Paul Sahni





REGISTERED OFFICE: 43A - 45 Church St
Bilston
United Kingdom
WV14 0AX





REGISTERED NUMBER: 12727107 (England and Wales)





ACCOUNTANTS: Brindleys Limited
2 Wheeleys Road
Edgbaston
Birmingham
West Midlands
B15 2LD

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Balance Sheet
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 683,709 723,928
Tangible assets 5 58,572 67,028
742,281 790,956

CURRENT ASSETS
Stocks 6 75,000 90,000
Debtors 7 596,190 523,237
Cash at bank and in hand 103,261 87,255
774,451 700,492
CREDITORS
Amounts falling due within one year 8 1,284,268 1,270,610
NET CURRENT LIABILITIES (509,817 ) (570,118 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

232,464

220,838

PROVISIONS FOR LIABILITIES 9 14,643 12,736
NET ASSETS 217,821 208,102

CAPITAL AND RESERVES
Called up share capital 10 1 1
Retained earnings 11 217,820 208,101
SHAREHOLDERS' FUNDS 217,821 208,102

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by:





Mohan Lal Sahni - Director


CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Church Pharma (Bilston) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 13 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 804,364
AMORTISATION
At 1 April 2023 80,436
Charge for year 40,219
At 31 March 2024 120,655
NET BOOK VALUE
At 31 March 2024 683,709
At 31 March 2023 723,928

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 April 2023 91,542 1,581 93,123
Additions 1,984 - 1,984
At 31 March 2024 93,526 1,581 95,107
DEPRECIATION
At 1 April 2023 25,403 692 26,095
Charge for year 10,218 222 10,440
At 31 March 2024 35,621 914 36,535
NET BOOK VALUE
At 31 March 2024 57,905 667 58,572
At 31 March 2023 66,139 889 67,028

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

6. STOCKS
2024 2023
£    £   
Stocks 75,000 90,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 151,250 189,380
Amounts owed by group undertakings 417,892 300,224
VAT 19,263 23,124
Prepayments 7,785 10,509
596,190 523,237

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 206,092 213,137
Amounts owed to group undertakings 963,430 935,077
Tax 50,100 67,253
Social security and other taxes 2,791 3,106
Other creditors 50,923 31,136
Accrued expenses 10,932 20,901
1,284,268 1,270,610

9. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 14,643 12,736

Deferred
tax
£   
Balance at 1 April 2023 12,736
Provided during year 1,907
Balance at 31 March 2024 14,643

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary A 1 1 1

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

11. RESERVES
Retained
earnings
£   

At 1 April 2023 208,101
Profit for the year 99,719
Dividends (90,000 )
At 31 March 2024 217,820